Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension

Nitric Oxide - Biology and Chemistry

Volumn 27, Issue 1, 2012, Pages 1-8

  Pankey, Edward A ^a   Badejo, Adeleke M ^a   Casey, David B ^a   Lasker, George F ^a   Riehl, Russel A ^a   Murthy, Subramanyam N ^a   Nossaman, Bobby D ^a,b   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OCHSNER MEDICAL CENTER   (United States)

Author keywords

Monocrotaline; Nitric oxide; Pulmonary hypertension therapy; Pulmonary vascular bed; Right ventricular hypertrophy; Sodium nitrite

Indexed keywords

2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL] 5 MORPHOLINO 4,6 PYRIMIDINEDIAMINE; MONOCROTALINE; NITROPRUSSIDE SODIUM; SODIUM NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEART OUTPUT; HEART RIGHT VENTRICLE; LUNG ARTERY PRESSURE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMICS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; LUNG; MONOCROTALINE; MORPHOLINES; NITRIC OXIDE; NITROPRUSSIDE; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM NITRITE; TUNICA MEDIA;

ANIMALIA; RATTUS; RODENTIA;

EID: 84861583836     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2012.02.004     Document Type: Article

References (82)

1. L.J. Rubin, and D.B. Badesch Evaluation and management of the patient with pulmonary arterial hypertension Ann. Intern. Med. 143 2005 282 292
2. G. Simonneau, N. Galie, L.J. Rubin, D. Langleben, W. Seeger, G. Domenighetti, S. Gibbs, D. Lebrec, R. Speich, M. Beghetti, S. Rich, and A. Fishman Clinical classification of pulmonary hypertension J. Am. Coll. Cardiol. 43 2004 5S 12S
3. A. Widlitz, and R.J. Barst Pulmonary arterial hypertension in children Eur. Respir. J. 21 2003 155 176
4. A. Raiesdana, and J. Loscalzo Pulmonary arterial hypertension Ann. Med. 38 2006 95 110
5. S.G. Haworth, and A.A. Hislop Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006 Heart 95 2009 312 317
6. Y. Toyoda, J. Thacker, R. Santos, D. Nguyen, J. Bhama, C. Bermudez, R. Kormos, B. Johnson, M. Crespo, J. Pilewski, J. Teuteberg, R. Alvarez, M. Mathier, D. McNamara, K. McCurry, M. Zenati, and B. Hattler Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension Ann. Thorac. Surg. 86 2008 1116 1122
7. L.J. Rubin Pulmonary arterial hypertension Proc. Am. Thorac. Soc. 3 2006 111 115
8. N. Galie, and A. Branzi Pulmonary arterial hypertension: therapeutic algorithm Ital. Heart. J. 6 2005 856 860
9. L.J. Ignarro Nitric oxide as a unique signaling molecule in the vascular system: a historical overview J. Physiol. Pharmacol. 53 2002 503 514
10. L.J. Ignarro Nitric oxide: a unique endogenous signaling molecule in vascular biology Biosci. Rep. 19 1999 51 71
11. M.W. Radomski, and S. Moncada Regulation of vascular homeostasis by nitric oxide Thromb. Haemost. 70 1993 36 41
12. K. Bian, and F. Murad Nitric oxide (NO) - biogeneration, regulation, and relevance to human diseases Front Biosci 8 2003 d264 d278
13. L.N. Cook, and D.L. Stewart Inhaled nitric oxide in the treatment of persistent pulmonary hypertension/hypoxic respiratory failure in neonates: an update J. Ky. Med. Assoc. 103 2005 138 147
14. G.F. Rich, G.D. Murphy Jr., C.M. Roos, and R.A. Johns Inhaled nitric oxide. Selective pulmonary vasodilation in cardiac surgical patients Anesthesiology 78 1993 1028 1035
15. R.W. Taylor, J.L. Zimmerman, R.P. Dellinger, R.C. Straube, G.J. Criner, K. Davis Jr., K.M. Kelly, T.C. Smith, and R.J. Small Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial JAMA 291 2004 1603 1609
16. R.P. Dellinger, J.L. Zimmerman, R.W. Taylor, R.C. Straube, D.L. Hauser, G.J. Criner, K. Davis Jr., T.M. Hyers, and P. Papadakos Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled nitric oxide in ARDS study group Crit. Care Med. 26 1998 15 23
17. A. Giaid, and D. Saleh Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension N. Engl. J. Med. 333 1995 214 221
18. H.C. Champion, T.J. Bivalacqua, S.S. Greenberg, T.D. Giles, A.L. Hyman, and P.J. Kadowitz Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice Proc. Natl. Acad. Sci. USA 99 2002 13248 13253
19. L. Goret, S. Tanguy, I. Guiraud, M. Dauzat, and P. Obert Acute administration of l-arginine restores nitric oxide-mediated relaxation in isolated pulmonary arteries from pulmonary hypertensive exercise trained rats Eur. J. Pharmacol. 581 2008 148 156
20. E. Weitzberg, A. Rudehill, and J.M. Lundberg Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock Eur. J. Pharmacol. 233 1993 85 94
21. B.R. Jacobs, R.J. Brilli, E.T. Ballard, D.J. Passerini, and D.J. Smith Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury Am. J. Respir. Crit. Care Med. 158 1998 1536 1542
22. N.S. Bryan Cardioprotective actions of nitrite therapy and dietary considerations Front. Biosci. 14 2009 4793 4808
23. J.O. Lundberg Cardiovascular prevention by dietary nitrate and nitrite Am. J. Physiol. Heart Circ. Physiol. 296 2009 H1221 H1223
24. J.W. Calvert, and D.J. Lefer Clinical translation of nitrite therapy for cardiovascular diseases Nitric Oxide 22 2009 91 97
25. A.B. Weisse, and T.J. Regan The current status of nitrites in the treatment of coronary artery disease Prog. Cardiovasc. Dis. 12 1969 72 82
26. A.J. Webb, A.B. Milsom, K.S. Rathod, W.L. Chu, S. Qureshi, M.J. Lovell, F.M. Lecomte, D. Perrett, C. Raimondo, E. Khoshbin, Z. Ahmed, R. Uppal, N. Benjamin, A.J. Hobbs, and A. Ahluwalia Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase Circ. Res. 103 2008 957 964
27. T.S. Isbell, M.T. Gladwin, and R.P. Patel Hemoglobin oxygen fractional saturation regulates nitrite-dependent vasodilation of aortic ring bioassays Am. J. Physiol. Heart Circ. Physiol. 293 2007 H2565 H25672
28. A. Dejam, C.J. Hunter, C. Tremonti, R.M. Pluta, Y.Y. Hon, G. Grimes, K. Partovi, M.M. Pelletier, E.H. Oldfield, R.O. Cannon 3rd, A.N. Schechter, and M.T. Gladwin Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation Circulation 116 2007 1821 1831
29. K. Cosby, K.S. Partovi, J.H. Crawford, R.P. Patel, C.D. Reiter, S. Martyr, B.K. Yang, M.A. Waclawiw, G. Zalos, X. Xu, K.T. Huang, H. Shields, D.B. Kim-Shapiro, A.N. Schechter, R.O. Cannon 3rd, and M.T. Gladwin Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation Nat. Med. 9 2003 1498 1505
30. M.P. Doyle, R.A. Pickering, T.M. DeWeert, J.W. Hoekstra, and D. Pater Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites J. Biol. Chem. 256 1981 12393 12398
31. E. Nagababu, S. Ramasamy, D.R. Abernethy, and J.M. Rifkind Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin- mediated nitrite reduction J. Biol. Chem. 278 2003 46349 46356
32. C.J. Hunter, A. Dejam, A.B. Blood, H. Shields, D.B. Kim-Shapiro, R.F. Machado, S. Tarekegn, N. Mulla, A.O. Hopper, A.N. Schechter, G.G. Power, and M.T. Gladwin Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator Nat. Med. 10 2004 1122 1127
33. S. Deem, J.-H. Min, J.D. Moulding, R. Eveland, and E.R. Swenson Red blood cells prevent inhibition of hypoxic pulmonary vasoconstriction by nitrite in isolated, perfused rat lungs Am. J. Physiol. Heart Circ. Physiol. 292 2007 H963 H970
34. D.B. Casey, A.M. Badejo Jr., J.S. Dhaliwal, S.N. Murthy, A.L. Hyman, B.D. Nossaman, and P.J. Kadowitz Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat Am. J. Physiol. Heart Circ. Physiol. 296 2009 H524 H533
35. C. Heiss, T. Lauer, A. Dejam, P. Kleinbongard, S. Hamada, T. Rassaf, S. Matern, M. Feelisch, and M. Kelm Plasma nitroso compounds are decreased in patients with endothelial dysfunction (see comment) J. Am. Coll. Cardiol. 47 2006 573 579
36. P. Kleinbongard, A. Dejam, T. Lauer, T. Jax, S. Kerber, P. Gharini, J. Balzer, R.B. Zotz, R.E. Scharf, R. Willers, A.N. Schechter, M. Feelisch, and M. Kelm Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans Free Radic. Biol. Med. 40 2006 295 302
37. T.L. Brunton On the use of nitrite of amyl in angina pectoris Lancet 2 1867 97 98
38. S. Weiss, and L.B. Ellis Influence of sodium nitrite on the cardiovascular system and on renal activity Arch. Intern. Med. 52 1933 105 119
39. R.F. Furchgott, and S. Bhadrakom Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs J. Pharmacol. Exp. Ther. 108 1953 129 143
40. L.J. Ignarro, and C.A. Gruetter Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols Biochim. Biophys. Acta 631 1980 221 231
41. C.A. Gruetter, D.Y. Gruetter, J.E. Lyon, P.J. Kadowitz, and L.J. Ignarro Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin J. Pharmacol. Exp. Ther. 219 1981 181 186
42. L.J. Ignarro, H. Lippton, J.C. Edwards, W.H. Baricos, A.L. Hyman, P.J. Kadowitz, and C.A. Gruetter Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates J. Pharmacol. Exp. Ther. 218 1981 739 749
43. M. Feelisch, and M. Kelm Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells Biochem. Biophys. Res. Commun. 180 1991 286 293
44. W.P. Arnold, C.K. Mittal, S. Katsuki, and F. Murad Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations Proc. Natl. Acad. Sci. USA 74 1977 3203 3207
45. S. Katsuki, W. Arnold, C. Mittal, and F. Murad Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine J. Cyclic Nucleotide Res. 3 1977 23 35
46. S. Katsuki, W.P. Arnold, and F. Murad Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues J Cyclic Nucleotide Res 3 1977 239 247
47. S. Shiva, Z. Huang, R. Grubina, J. Sun, L.A. Ringwood, P.H. MacArthur, X. Xu, E. Murphy, V.M. Darley-Usmar, and M.T. Gladwin Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration Circ. Res. 100 2007 654 661
48. K. Cosby, K.S. Partovi, J.H. Crawford, R.P. Patel, C.D. Reiter, S. Martyr, B.K. Yang, M.A. Waclawiw, G. Zalos, X. Xu, K.T. Huang, H. Shields, D.B. Kim-Shapiro, A.N. Schechter, R.O. Cannon 3rd, and M.T. Gladwin Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation (see comment) Nat. Med. 9 2003 1498 1505
49. Z. Huang, S. Shiva, D.B. Kim-Shapiro, R.P. Patel, L.A. Ringwood, C.E. Irby, K.T. Huang, C. Ho, N. Hogg, A.N. Schechter, and M.T. Gladwin Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control J. Clin. Invest. 115 2005 2099 2107
50. K.T. Huang, A. Keszler, N. Patel, R.P. Patel, M.T. Gladwin, D.B. Kim-Shapiro, and N. Hogg The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry J. Biol. Chem. 280 2005 31126 31131
51. A.M. Badejo Jr., C. Hodnette, J.S. Dhaliwal, D.B. Casey, E. Pankey, S.N. Murthy, B.D. Nossaman, A.L. Hyman, and P.J. Kadowitz Mitochondrial aldehyde dehydrogenase mediates vasodilator responses of glyceryl trinitrate and sodium nitrite in the pulmonary vascular bed of the rat Am. J. Physiol. Heart Circ. Physiol. 299 2010 H819 H826
52. N.H. Golwala, C. Hodenette, S.N. Murthy, B.D. Nossaman, and P.J. Kadowitz Vascular responses to nitrite are mediated by xanthine oxidoreductase and mitochondrial aldehyde dehydrogenase in the rat Can. J. Physiol. Pharmacol. 87 2009 1095 1101
53. A.B. Blood, H.J. Schroeder, M.H. Terry, J. Merrill-Henry, S.L. Bragg, K. Vrancken, T. Liu, J.L. Herring, L.C. Sowers, S.M. Wilson, and G.G. Power Inhaled nitrite reverses hemolysis-induced pulmonary vasoconstriction in newborn lambs without blood participation Circulation 123 2011 605 612
54. A.B. Blood, and G.G. Power In vitro and in vivo kinetic handling of nitrite in blood: effects of varying hemoglobin oxygen saturation Am. J. Physiol. Heart Circ. Physiol. 293 2007 H1508 H1517
55. B.S. Zuckerbraun, S. Shiva, E. Ifedigbo, M.A. Mathier, K.P. Mollen, J. Rao, P.M. Bauer, J.J. Choi, E. Curtis, A.M. Choi, and M.T. Gladwin Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation Circulation 121 2010 98 109
56. J.O. Lundberg, E. Weitzberg, and M.T. Gladwin The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics Nat Rev Drug Discov 7 2008 156 167
57. B.S. Zuckerbraun, P. George, and M.T. Gladwin Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling Cardiovasc. Res. 89 2011 542 552
58. A.L. Kleschyov, M. Oelze, A. Daiber, Y. Huang, H. Mollnau, E. Schulz, K. Sydow, B. Fichtlscherer, A. Mulsch, and T. Munzel Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circ. Res. 93 2003 e104 e112
59. A. Kollau, M. Beretta, M. Russwurm, D. Koesling, W.M. Keung, K. Schmidt, and B. Mayer Mitochondrial nitrite reduction coupled to soluble guanylate cyclase activation: lack of evidence for a role in the bioactivation of nitroglycerin Nitric Oxide 20 2009 53 60
60. M.V. Wenzl, M. Beretta, M. Griesberger, M. Russwurm, D. Koesling, K. Schmidt, B. Mayer, and A.C. Gorren Site-directed mutagenesis of aldehyde dehydrogenase-2 suggests three distinct pathways of nitroglycerin biotransformation Mol. Pharmacol. 80 2011 258 266
61. C. Nunez, V.M. Victor, R. Tur, A. Alvarez-Barrientos, S. Moncada, J.V. Esplugues, and P. D'Ocon Discrepancies between nitroglycerin and NO-releasing drugs on mitochondrial oxygen consumption, vasoactivity, and the release of NO Circ. Res. 97 2005 1063 1069
62. T.C. Murphy, R. Arntzen, and M.J. Picklo Sr. Nitrate-based vasodilators inhibit multiple vascular aldehyde dehydrogenases Cardiovasc. Toxicol. 5 2005 321 332
63. J.S. Dhaliwal, A.M. Badejo Jr., D.B. Casey, S.N. Murthy, and P.J. Kadowitz Analysis of pulmonary vasodilator responses to SB-772077-B [4-(7-((3-amino-1-pyrrolidinyl)carbonyl)-1-ethyl-1H-imidazo(4,5-c)pyridin-2-yl) -1,2,5-oxadiazol-3-amine], a novel aminofurazan-based Rho kinase inhibitor J. Pharmacol. Exp. Ther. 330 2009 334 341
64. D.J. Lefer Emerging role of nitrite in myocardial protection Arch. Pharm. Res. 32 2009 1127 1138
65. J.D. Artz, V. Toader, S.I. Zavorin, B.M. Bennett, and G.R. Thatcher In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics Biochemistry 40 2001 9256 9264
66. B. Mayer, and M. Beretta The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles Br. J. Pharmacol. 155 2008 170 184
67. W. Murrell Nitro-glycerine in angina pectoris Lancet 1 1879 80 81
68. T. Dalsgaard, U. Simonsen, and A. Fago Nitrite-dependent vasodilation is facilitated by hypoxia and is independent of known NO-generating nitrite reductase activities Am. J. Physiol. Heart Circ. Physiol. 292 2007 H3072 H3078
69. T.M. Millar, C.R. Stevens, N. Benjamin, R. Eisenthal, R. Harrison, and D.R. Blake Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions FEBS Lett. 427 1998 225 228
70. A.G. Pinder, E. Pittaway, K. Morris, and P.E. James Nitrite directly vasodilates hypoxic vasculature via nitric oxide-dependent and -independent pathways Br. J. Pharmacol. 157 2009 1523 1530
71. Z. Chen, M.W. Foster, J. Zhang, L. Mao, H.A. Rockman, T. Kawamoto, K. Kitagawa, K.I. Nakayama, D.T. Hess, and J.S. Stamler An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation Proc. Natl. Acad. Sci. USA 102 2005 12159 12164
72. Z. Chen, J. Zhang, and J.S. Stamler Identification of the enzymatic mechanism of nitroglycerin bioactivation Proc. Natl. Acad. Sci. USA 99 2002 8306 8311
73. M. Beretta, K. Gruber, A. Kollau, M. Russwurm, D. Koesling, W. Goessler, W.M. Keung, K. Schmidt, and B. Mayer Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases J. Biol. Chem. 283 2008 17873 17880
74. M. Beretta, G. Wolkart, M. Schernthaner, M. Griesberger, R. Neubauer, K. Schmidt, M. Sacherer, F.R. Heinzel, S.D. Kohlwein, and B. Mayer Vascular bioactivation of nitroglycerin is catalyzed by cytosolic aldehyde dehydrogenase-2 Circ. Res. 110 2012 385 393
75. E.A. Jansson, L. Huang, R. Malkey, M. Govoni, C. Nihlen, A. Olsson, M. Stensdotter, J. Petersson, L. Holm, E. Weitzberg, and J.O. Lundberg A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis Nat. Chem. Biol. 4 2008 411 417
76. L.J. Ignarro, R.E. Byrns, G.M. Buga, and K.S. Wood Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical Circ. Res. 61 1987 866 879
77. J.C. Edwards, L.J. Ignarro, A.L. Hyman, and P.J. Kadowitz Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP J. Pharmacol. Exp. Ther. 228 1984 33 42
78. J.M. Braughler, C.K. Mittal, and F. Murad Effects of thiols, sugars, and proteins on nitric oxide activation of guanylate cyclase J. Biol. Chem. 254 1979 12450 12454
79. J. Garthwaite, E. Southam, C.L. Boulton, E.B. Nielsen, K. Schmidt, and B. Mayer Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one Mol. Pharmacol. 48 1995 184 188
80. C.L. Boulton, E. Southam, and J. Garthwaite Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase Neuroscience 69 1995 699 703
81. A.L. Hyman, B.M. Chapnick, P.J. Kadowitz, W.E. Lands, C.G. Crawford, J. Fried, and J. Barton Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids PNAS 74 1977 5711 5715
82. A.L. Hyman, and P.J. Kadowitz Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat Circ. Res. 45 1979 404 409